Syringoma
https://en.wikipedia.org/wiki/Syringoma
☆ AI Dermatology — Free ServiceNa nsonaazụ Stiftung Warentest nke 2022 sitere na Germany, afọ ojuju ndị ahịa na ModelDerm dị ntakịrị ntakịrị karịa na nyocha telemedicine akwụ ụgwọ. 

Syringoma okirikiri ọcha na-eme ka ọ pụta ìhè; ụdị ọnya a na-emekarị n’ime ụmụ nwanyị dị n’oge iri anọ na iri ise. Ọgwụgwọ laser (pinhole method) nwere ike ịdị irè n'ịkwalite ọdịdị ọnya ahụ.
relevance score : -100.0%
References
Cutaneous Syringoma: A Clinicopathologic Study of 34 New Cases and Review of the Literature 23919023 NIH
E kewara ndị ọrịa iri atọ na anọ n'ụdị abụọ (localized and generalized syringoma). Ndị ọrịa ahụ bụkarị ụmụ nwanyị, na-anọ pasentị iri itoolu na asaa, na nkezi afọ 28. Tupu ịchọ ọgwụgwọ, ọnya ahụ adịla ihe dịka afọ isii. Generalized syringoma na-emetụkarị igbe, olu, na aka, ebe a na-ahụkarị localized syringoma n'ihu, n'axilla, na akụkụ ndị ọzọ nke ahụ.
Thirty-four patients were sorted into two groups, localized and generalized syringoma, according to the Friedman and Butler classification. Ninety-seven percent of the patients were females with the mean age of 27.6 years. The mean duration of the lesions before the presentations was six years. Distribution of the generalized syringoma was mainly in the chest and neck followed by the forearms whereas localized syringoma was mostly confined to the face, axilla and genitalia.
Syringoma: A Clinicopathologic and Immunohistologic Study and Results of Treatment 17326243 NIH
Ọmụmụ ihe anyị bu n'obi bụ ịkọwapụta ihe gbasara ahụike na akụkọ ihe mere eme nke ndị ọrịa iri isii, ndị chọpụtara syringoma n'ime afọ anọ n'ụlọọgwụ dermatology anyị na Korea. Anyị hụrụ na syringoma na-emetụtakarị ụmụ nwanyị, yana ọnụ ọgụgụ bụ ụmụ nwanyị isii (6) na nwoke otu (1). Ọ na-apụtakarị n'afọ nke abụọ ruo iri atọ nke ndụ, na ihe karịrị ọkara nke ndị ọrịa. Ebe kachasị emetụta bụ nku anya (71%), ebe ọnya na-abụkarị agba akpụkpọ (49%). Anyi hụrụ ọdịdị tadpole, nke a na-eji mara ya, na 56% nke ikpe. A na-ahụkarị hyperpigmentation basal na ọnya na-acha aja aja, ebe fibrosis na-adịkarị na ọnya erythematous. Na mgbakwunye, cysts keratin adịghịkarị n'ógbè ndị metụtara akụkụ ahụ.
The purpose of our study was to describe clinical and histopathological features of sixty one patients with histological diagnosis of syringoma over four year period in our dermatology clinic in Korea. Female:male ratio was 6.6:1 with onset of age during 2nd and 3rd decades in more than half of the patients in our study. The most frequently involved site was eyelids (43 cases, 70.5%) and the most common color of lesion was skin-color (30 cases, 49.2%). In 34 cases, characteristic tad-pole appearances (55.7%) were observed. Basal hyperpigmentation was observed more frequently in brown-colored lesion (p=0.005). Fibrosis was observed more frequently in erythematous lesion (p=0.033). Keratin cyst was observed less frequently in genital involved group (p=0.006).
Evaluation of the Pinhole Method Using Carbon Dioxide Laser on Facial Telangiectasia 37109186 NIH
[Pinhole technique] - CO2 ọgwụgwọ laser na-eji usoro pinhole na-agwọ telangiectasias ihu bụ ọgwụgwọ dị mma, dị ọnụ ala, ma dị irè, nke na-enye ndị ọrịa afọ ojuju.
[Pinhole technique] - CO2 laser treatment using the pinhole method to treat facial telangiectasias is a safe, inexpensive, and effective treatment that provides patients with excellent aesthetic satisfaction.
○ Ọgwụgwọ
#Pinhole technique (Erbium or CO2 laser)